Karyopharm Therapeutics (KPTI)'s 30-day implied volatility (IV30) was 202.2% at the close on November 10, 2026, up from 196.5% the day before, against a 52-week range of 61.5% to 400.0%. Its 20-day historical volatility was 273.8%.
Data as of November 10, 2026.